A national study of the processes and outcomes of paediatric formulary applications in Australia-Reference-Cited by-同舟云学术

A national study of the processes and outcomes of paediatric formulary applications in Australia

Published:2014-05 Issue:9 Volume:200 Page:541-545
ISSN:0025-729X
Container-title:Medical Journal of Australia
language:en
Short-container-title:Medical Journal of Australia

Author:

Sinha Yashwant K¹²,Craig Jonathan C³,Barclay Peter G¹,Miller Hugh⁴,Turner Sean C¹,Whitehouse Joseph P⁵,Brien Jo‐anne E⁶

Affiliation:

1. The Children's Hospital at Westmead, Sydney, NSW.

2. Women's and Children's Hospital, Adelaide, SA.

3. Sydney School of Public Health, University of Sydney, Sydney, NSW.

4. Royal Children's Hospital, Brisbane, QLD.

5. Flinders Medical Centre, Adelaide, SA.

6. St Vincent's Hospital, University of Sydney, Sydney, NSW.

Publisher

AMPCo

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.5694/mja13.11138

Reference20 articles.

1. A survey of pharmacy and therapeutic committees across Canada: scope and responsibilities;Mittmann N;Can J Clin Pharmacol,2009

2. Provision of pharmaceuticals in Australian hospitals: equity of access?

3. Hospital Drug and Therapeutics Committees in Australia: is there a role for economic evaluation at the institutional level?

4. Queensland Government.List of approved medicines.http://www.health.qld.gov.au/qhcss/mapsu/sdl.asp(accessed Jul 2013).

5. Western Australian Therapeutic Advisory Group.Western Australian Drug Evaluation Panel.http://www.watag.org.au/wadep/index.cfm#about(accessed Nov 2013).

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The outcomes of a national clinical review process for n onformulary medication requests in Saudi Arabia;JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY;2022-09-16

2. The National Paediatric Medicines Forum: Who we are and what are we doing;Journal of Paediatrics and Child Health;2021-10-13

3. South Australian Medicines Evaluation Panel in review: providing evidence-based guidance on the use of high-cost medicines in the South Australian public health system;Australian Health Review;2021

4. “There are ways … drug companies will get into DTC decisions”: How Australian drug and therapeutics committees address pharmaceutical industry influence;British Journal of Clinical Pharmacology;2020-11-26

5. The development of funding recommendations for health technologies at the state level: A South Australian case study;The International Journal of Health Planning and Management;2018-04-20